Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Recessive Optic Atrophy Due to WFS1 is a Specific Entity Different From Wolfram Syndrome?

NCT07336966 is registered in ClinicalTrials.gov with Hôpital Necker-Enfants Malades as lead sponsor.

NCT NCT07336966
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07336966 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Recessive Optic Atrophy Due to WFS1 is a Specific Entity Different From Wolfram Syndrome?
Lead sponsor
Hôpital Necker-Enfants Malades
Phase
Observational
Overall status
Not yet recruiting
Start date
February 28, 2026
Completion date
April 30, 2026
Enrollment
45 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

optic atrophies, hereditary, wolfram syndrome 1